Zhitong Finance App News, Hengrui Pharmaceutical (600276.SH) issued an announcement. Recently, the company's product SHR-4375 injection for the treatment of pancreatic cancer was certified as an orphan drug by the US Food and Drug Administration (“US FDA”). Orphan medicines, also known as rare disease drugs, refer to drugs used to prevent, treat, and diagnose rare diseases. The company has been certified as an orphan drug by the US FDA and will have the opportunity to enjoy US policy support in product development, registration and commercialization.

Zhitong Finance App News, Hengrui Pharmaceutical (600276.SH) issued an announcement. Recently, the company's product SHR-4375 injection for the treatment of pancreatic cancer was certified as an orphan drug by the US Food and Drug Administration (“US FDA”). Orphan medicines, also known as rare disease drugs, refer to drugs used to prevent, treat, and diagnose rare diseases. The company has been certified as an orphan drug by the US FDA and will have the opportunity to enjoy US policy support in product development, registration and commercialization.